Log inSign up
Matteo Lambertini, MD PhD
12.6K posts
user avatar
Matteo Lambertini, MD PhD
@matteolambe
Associate Professor at @UniGenova & Director of the Medical Oncology Unit at #GallieraHospital. SoMe Editor for @JCO_ASCO. Fellow of @myESMO. #BreastCancer
Joined December 2012
470
Following
19.1K
Followers

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • Pinned
    user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Dec 7, 2023
    Presented today at #SABCS23 and published in @JAMA_current results of our study showing the feasibility and safety of #pregnancy after #BreastCancer in young #BRCA carriers @OncoAlert @SABCSSanAntonio @AACR @UniGenova @SanMartino_Ge #bcsm Link here: jamanetwork.com/journals/jama/…
    28K
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    May 3, 2023
    Finally out in @NEJM results from #POSITIVE trial showing that temporary interruption of #EndocrineTherapy to attempt #pregnancy is safe in #BreastCancer patients: this is wonderful news…super congrats @AnnPartridgeMD @etop_ibcsg et al! @OncoAlert #bcsm nejm.org/doi/full/10.10…
    101K
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Mar 19, 2025
    Just published in @JCO_ASCO the updated @ASCO guidelines on fertility preservation in people with #cancer: a must read for all colleagues involved in cancer care to increase awareness on #oncofertility issues @OncoAlert @AnnPartridgeMD @oncofertility Link: ascopubs.org/doi/10.1200/JC…
    54K
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Jul 1, 2021
    Honored and excited to share our large #metanalysis presented at #SABCS20 now published in @ASCO_pubs #JCO providing solid and reassuring evidence on fetal and maternal safety of #pregnancy after prior #BreastCancer history @OncoAlert #SurvOnc #bcsm Link: ascopubs.org/doi/full/10.12…
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Jan 31, 2023
    From January 1, 2023 I have been appointed as Chair of @myESMO Young Oncologists Committee #ESMOYOC...a big THANK YOU to all the people that have helped me to achieve this position and to those that will contribute in the next 2 years to succeed in our mission! @OncoAlert
    42K
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Jun 5, 2022
    This person is a young oncologist... This person is Italian... This person is the discussant at the #ASCO22 plenary session... @ChiaraCrem1 is the Queen of Italy 🇮🇹🔥❤️🔝💪🤩 #ItalianPride @OncoAlert @ASCO @ASCOPost @ConquerCancerFd @JCO_ASCO @AIOMtweet
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Feb 18, 2025
    February 18, 2025 the third best day of my life…welcome Luigi !!! 🩵 @SanMartino_Ge @UniGenova @OncoAlert #grateful #thankful #papàtris
    13K
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Sep 6, 2021
    ..the second best day of my life..benvenuto Ruggero..Giulia, Agnese and I are so excited to welcome you in our family!!! 💙👨‍👩‍👧‍👦🎉 #RuggeroLambertini #welcome #FamilyIsGrowing #FamilyFirst #proudDaddy #papàbis #doubledad #6thSeptember2021 #OspedaleSanMartino #UNIGE #UNIGEnonsiferma
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Sep 18, 2021
    !!!!!! #ESMO21 @myESMO @OncoAlert
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    May 27, 2023
    Finally out the #ASCO23 Educational Book with our contribution on managing menopausal symptoms, #fertility preservation & bone health in #BreastCancer patients receiving #EndocrineTherapy Link for free download: ascopubs.org/doi/10.1200/ED… @ASCO @kristinrojasmd @Lucarecco @OncoAlert
    33K
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Dec 9, 2022
    Finally the controversy on #carboplatin use as part of neoadjuvant #chemotherapy in triple-negative #BreastCancer patients is over: super congrats to our Indian colleagues for running such an important academic trial! @OncoAlert @SABCSSanAntonio @Poggio_Fra #bcsm #SABCS22
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Feb 1, 2022
    February 1, 2022 Finally, super excited and honored to become Associate Professor in medical oncology at @UniGenova @SanMartino_Ge...many many thanks to all the people that have supported me over the past years...ready for this new challenge ! @OncoAlert #UNIGEnonsiferma #UNIGE
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Jul 16, 2020
    Finally out in @ASCO_pubs our #ASCO19 data: strong evidence to state that #pregnancy after #BreastCancer is safe in patients with germline #BRCA mutations and should not be discouraged @ASCO #OncoAlert #JCO #bcsm #UNIGEnonsiferma @UniGenova @SanMartino_Ge
    ascopubs.org
    Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations
    PURPOSEYoung women with germline BRCA mutations have unique reproductive challenges. Pregnancy after breast cancer does not increase the risk of recurrence; however, very limited data are available...
  • user avatar
    Matteo Lambertini, MD PhD
    @matteolambe
    Jun 5, 2022
    Finally it’s time for the #DESTINYbreast04 trial at #ASCO22 plenary session: so excited to be in the 2nd row of this big room to see such unprecedented results in the #BreastCancer field...this will remain one of the most important moment in the history of this disease @OncoAlert